F081 The Art of Healing- Scar Management Strategies Tailored to Ethnic Skin
DESCRIPTION
In this session, you will encounter innovative approaches to scar treatment for different skin types. Experts will unveil scar treatment protocols that utilize a combination of lasers, cryotherapy, IPL, LLLT, injections, dressings, and garments, highlighting the differences in approaches while outlining treatment steps, parameters of the main devices, anti-fibrotic dosages, and combination treatments to achieve the best possible results for various skin tones. You will also learn how to address patients with severe cases of large burn scars and keloidal diathesis, particularly concerning their self-esteem. Additionally, techniques for scar refinement will be demonstrated, including repigmentation of achromic scars, treatment of hyperchromic scars, and management of atrophic scars. The second part of our session will include Pearls on how to employ technologies to treat keloids, hypertrophic scars, and acne scars.
LEARNING OBJECTIVES
Perform different techniques to treat acne scars in ethnic skin, with special emphasis in technologies and procedures
Describe non-surgical and surgical techniques to treat keloids and hypertrophic scars in ethnic skin; pearls on how to employ technologies and procedures in order to treat scars and keloids will be shown.
Discuss scar treatment protocols with lasers, cryotherapy, IPL, LLLT, injections, dressings and garments- outline detailed scar treatment steps, parameters of the main devices, anti-fibrotic dosages and the combination treatments to achieve the best possible results.
SCHEDULE
9:00 AM
Comprehensive management of acne scarring
Alexandra Y. Zhang, MD, FAAD
9:15 AM
Beyond surgery: Treatment of Keloids and Hypertrophic Scars using a combined approach in ethnic skin
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
9:30 AM
Pearl: the best combinations and single uses of anti fibrosant drugs in ethnic skin
Leandra d'Orsi Metsavaht, MD, IFAAD
9:40 AM
Pearl: Tips and tricks to employ botulinum toxin in scars with the best results
Doris M Hexsel, MD, IFAAD
9:50 AM
Pearl: my prefered laser combination to treat hypertrophic scars in Phototypes IV-VI
Alexandre De Almeida Filippo, MD, IFAAD
10:00 AM
My pearl to the safe use of microneedling in the hispanic population and phototypes III-VI
Daniela Araucaria Guzman Sanchez, MD, IFAAD
10:10 AM
Pearl: how to employ surgery and radiotherapy to treat keloids in higher phototypes
Michael H. Gold, MD, FAAD
10:20 AM
Pearl: Strategies for the Management of Pigmentary Changes in Scarring
Henry H.L. Chan, MD, PhD, IFAAD
10:30 AM
Pearl: my prefered laser combination to treat acne scars in ethnic skin
Ariel Haus, MD, IFAAD
10:40 AM
Q&Rs (Questions & Responses)
DIRECTOR
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
SPEAKERS
Henry H.L. Chan, MD, PhD, IFAAD
Alexandre De Almeida Filippo, MD, IFAAD
Michael H. Gold, MD, FAAD
Daniela Araucaria Guzman Sanchez, MD, IFAAD
Ariel Haus, MD, IFAAD
Doris M Hexsel, MD, IFAAD
Leandra d'Orsi Metsavaht, MD, IFAAD
Alexandra Y. Zhang, MD, FAAD
DISCLOSURES
Henry H.L. Chan, MD, PhD, IFAAD
AbbVie Inc – Consultant (1099 relationship)(Fees); AVAVA, LLC – Board of Directors(Stock Options); Blossom Innovations, LLC – Board of Directors(Stock Options); Boehringer Ingelheim – Advisory Board(Honoraria); Clarity Cosmetics, Inc. – Stockholder Private Company(Stock Options); Cutera, Inc. – Other(Equipment); Cynosure, Inc. – Investigator(Other Financial Benefit); Cytrellis Biosystems, Inc – Stockholder Private Company(Stock); Eli Lilly Asia Inc – Speaker/Faculty Education(Honoraria); Massachusetts General Hospital – Employee (w-2 relationship)(Patent royalties or other compensation for Intellectual Property Rights); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); R2 Dermatology, Inc. – Investigator(Other Financial Benefit); Sofwave – Investigator(Fees); Solta Medical Hong Kong Ltd – Speaker/Faculty Education(Honoraria); UCB Pharma (Hong Kong) Ltd – Advisory Board(Fees);
Alexandre De Almeida Filippo, MD, IFAAD
No financial relationships exist with ineligible companies.
Michael H. Gold, MD, FAAD
Acclaro Medical – Consultant (1099 relationship)(Honoraria); Aerolase – Stockholder(Honoraria); Aesthetic Management Partners – Consultant (1099 relationship)(Honoraria); Aesthetics Biomedical – Consultant (1099 relationship)(Honoraria); Alastin Skincare, Inc – Consultant (1099 relationship)(Honoraria); Allergan, Inc – Consultant(Honoraria); Alma Lasers – Speaker(Honoraria); Bausch Health – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Benev – Consultant (1099 relationship)(Honoraria); Cutera, Inc. – Speaker(Honoraria); EndyMed Medical Inc. USA – Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); Hugel – Consultant (1099 relationship)(Honoraria); InMode – Consultant (1099 relationship)(Honoraria); La Mer – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Investigator(Grants/Research Funding); Lumenis – Speaker(Honoraria); Merz Pharmaceuticals, LLC – Speaker(Honoraria); Mindera – Consultant (1099 relationship)(Honoraria); MTF Biologics – Consultant (1099 relationship)(Honoraria); Nutrafol – Consultant (1099 relationship)(Honoraria); Pierre Fabre – Consultant (1099 relationship)(Honoraria); Prescriber's Choice – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revision Skincare – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Rohrer Aesthetics – Consultant (1099 relationship)(Honoraria); Sciton Inc. – Consultant (1099 relationship)(Honoraria); Sensus Healthcare – Consultant (1099 relationship)(Honoraria); Sente Labs – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); SkinCeuticals LLC – Consultant (1099 relationship)(Honoraria); SkinMedica, Inc. – Consultant (1099 relationship)(Honoraria); Sofwave – Consultant (1099 relationship)(Honoraria); Stratapharma – Consultant (1099 relationship)(Honoraria); Venus Concept – Consultant(Stock Options), Speaker(Honoraria); VIOL – Consultant (1099 relationship)(Honoraria);
Daniela Araucaria Guzman Sanchez, MD, IFAAD
No financial relationships exist with ineligible companies.
Ariel Haus, MD, IFAAD
No financial relationships exist with ineligible companies.
Doris M Hexsel, MD, IFAAD
No financial relationships exist with ineligible companies.
Leandra d'Orsi Metsavaht, MD, IFAAD
No financial relationships exist with ineligible companies.
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
No financial relationships exist with ineligible companies.
Alexandra Y. Zhang, MD, FAAD
No financial relationships exist with ineligible companies.